EXOZ
eXoZymes Accelerates Growth with Focus on Scaling Up and Execution in 2025
eXoZymes, a biotechnology innovator, has made significant progress in scaling up its operations and execution in 2025, as reported during their recent Q4 investor call. The company's focus on scaling up and execution was a major theme throughout the quarter, with notable highlights including the successful development of